| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 10/04/2001 | US20010026941 Methods and compositions for the introduction of molecules into cells |
| 10/04/2001 | US20010026940 Biopesticides |
| 10/04/2001 | US20010026939 Comprising a chimeric gene that expresses a polypeptide having insect toxicity properties of Bacillus thuringiensis crystal protein |
| 10/04/2001 | US20010026938 Containing DNA expressing the adenovirus protease; for gene transfer purposes, vaccines |
| 10/04/2001 | US20010026932 Agonist anti-CD40 molecules, including monoclonal antibodies, which can bind to and stimulate professional and non-professional human antigen-presenting cells; may be useful as antitumor agents |
| 10/04/2001 | US20010026931 Accelerates differentiation of megakaryocytes in the presence of IL-3, and acts as a thrombopoietin, and therefore an effective medicament to various diseases involving a decrease in platelets |
| 10/04/2001 | US20010026926 A target receptor protein whose signal transduction activity can be modulated by interaction with an extracellular signal, and an expressible recombinant gene encoding an exogenous test polypeptide from a polypeptide library; rapid, reliable |
| 10/04/2001 | US20010026920 Subsets of particles comprising different known amounts of ligand binding partner sepcific for analytes of interest; providing information relating to high-dose hook effects, dilutional linearity, interfering assay factors, etc. |
| 10/04/2001 | US20010026918 Reducing background signals; accuracy |
| 10/04/2001 | US20010026917 DNA detection device |
| 10/04/2001 | US20010026799 Genome with mutation expresses native immediate early gene from genome with delayed kinetics; gene therapy |
| 10/04/2001 | US20010026795 Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system |
| 10/04/2001 | US20010026794 Two heterologous DNA encoding gene products; prolonged half-life |
| 10/04/2001 | EP1144629A3 Further pro polypeptides and sequences thereof |
| 10/04/2001 | EP1138786A2 Specific and universal amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
| 10/04/2001 | EP1138785A2 Nucleic acid fragment primer or probe, and method of detecting polyhydroxyalkanoate synthesizing microorganism by using the same |
| 10/04/2001 | EP1138784A2 Method for determining the efficiency of nucleic acid amplifications |
| 10/04/2001 | EP1138783A2 Method for the efficiency-corrected real-time quantification of nucleic acids |
| 10/04/2001 | EP1138781A2 Method for Quantifying DNA binding activity of DNA binding proteins |
| 10/04/2001 | EP1138774A2 Defective recombinant adenoviruses expressing cytokines for use in antitumoral treatement |
| 10/04/2001 | EP1138773A2 Use of plasmids for the manufacture of a composition for vaccine treatment by human and animal |
| 10/04/2001 | EP1138772A1 Process for producing apelin |
| 10/04/2001 | EP1138771A1 Coffee endo-mannanase |
| 10/04/2001 | EP1138770A2 Polyhydroxyalkanoate synthase and gene encoding the same enzyme |
| 10/04/2001 | EP1138769A1 Recombinant L-alpha-glycerophosphate oxidase gene, and method for producing the same |
| 10/04/2001 | EP1138768A2 Apoptin-associating protein AAP-5 |
| 10/04/2001 | EP1138767A2 Disease resistance in vitis |
| 10/04/2001 | EP1138766A2 Process for preparing major histocompatibility antigen class II protein and materials having the same immobilized thereon |
| 10/04/2001 | EP1138765A1 Apoptin-associating proteins AAP-5 and AAP-6 |
| 10/04/2001 | EP1138764A2 Two-step reverse transcription |
| 10/04/2001 | EP1138763A2 Method for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 10/04/2001 | EP1138762A1 Method for immobilizing oligonucleotide on a carrier |
| 10/04/2001 | EP1138761A1 Method for immobilizing dna on a carrier |
| 10/04/2001 | EP1138760A1 Neural cultures |
| 10/04/2001 | EP1138694A1 Hirulog-like peptide |
| 10/04/2001 | EP1138693A1 Novel g protein-coupled receptor protein and dna thereof |
| 10/04/2001 | EP1138689A1 N8- and C8-linked purine bases as universal nucleosides used for oligonucleotide hybridization |
| 10/04/2001 | EP1138324A1 Treatment of neurodegenerative conditions with nimesulide |
| 10/04/2001 | EP1137949A1 Assays for compounds which increase phospholipase a2 activity |
| 10/04/2001 | EP1137947A2 Method for determining asthma susceptibility |
| 10/04/2001 | EP1137941A1 Protein scaffolds for antibody mimics and other binding proteins |
| 10/04/2001 | EP1137812A1 Dna-protein fusions and uses thereof |
| 10/04/2001 | EP1137811A2 Methods of identifying point mutations in a genome |
| 10/04/2001 | EP1137810A2 A$g(b)-PEPTIDE SCREENING ASSAY |
| 10/04/2001 | EP1137808A1 Methods for making recombinant cells |
| 10/04/2001 | EP1137806A1 Detection of rantes gene promoter polymorphisms |
| 10/04/2001 | EP1137805A1 Methods of facilitating vascular growth |
| 10/04/2001 | EP1137804A1 Method for detecting in vitro a target substance in a sample comprising the labelling of said substance with a reporter gene and the sequences required for expressing said reporter gene in vitro |
| 10/04/2001 | EP1137803A1 Method and kit for the characterization of antibiotic-resistance mutations in mycobacterium tuberculosis |
| 10/04/2001 | EP1137801A1 Method for detecting and/or quantifying a known function from a nucleic acid sample |
| 10/04/2001 | EP1137797A1 Expression system for factor viii |
| 10/04/2001 | EP1137796A2 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto |
| 10/04/2001 | EP1137793A2 Novel nucleic acid transferring agents, compositions containing them and uses |
| 10/04/2001 | EP1137792A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 10/04/2001 | EP1137791A2 Regulatory sequences of the mouse villin gene - use in transgenesis |
| 10/04/2001 | EP1137790A2 AN IMPROVED EFFICIENCY $i(AGROBACTERIUM)-MEDIATED PLANT TRANSFORMATION METHOD |
| 10/04/2001 | EP1137789A1 A method for manufacturing glycoproteins having human-type glycosylation |
| 10/04/2001 | EP1137788A1 Transgenic plant expressing maltogenic alpha-amylase |
| 10/04/2001 | EP1137787A1 Enhanced protein production in higher plants by n-terminal fusion of a ubiquitin or a cucumber mosaic virus coat protein peptide |
| 10/04/2001 | EP1137786A1 Virus coat protein/receptor chimeras and methods of use |
| 10/04/2001 | EP1137785A1 STREPTOCOCCAL C5a PEPTIDASE VACCINE |
| 10/04/2001 | EP1137784A1 Method for isolating and selecting genes coding for enzymes, and suitable culture medium |
| 10/04/2001 | EP1137783A2 Beta-1,3-galactosyltransferase homologs |
| 10/04/2001 | EP1137782A2 Method for regulating carotenoid biosynthesis in marigolds |
| 10/04/2001 | EP1137781A1 Mutants of rna polymerases with increased stability |
| 10/04/2001 | EP1137780A1 Therapeutic and diagnostic uses of protein tyrosine phosphatase tc-ptp |
| 10/04/2001 | EP1137779A2 Identification of senv genotypes |
| 10/04/2001 | EP1137778A1 Polypeptides and polynucleotides "basb040" from neisseria meningitidis and vaccine comprising said polypeptides and polynucleotides |
| 10/04/2001 | EP1137777A2 Novel compounds derived from neisseria meningitidis |
| 10/04/2001 | EP1137776A2 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 10/04/2001 | EP1137775A1 htfIIIA HUMAN GENE AND CODED hTFIIIA PROTEIN |
| 10/04/2001 | EP1137774A2 Grnf4, a gdnf-related neurotrophic factor |
| 10/04/2001 | EP1137773A2 Growth factor homolog zvegf3 |
| 10/04/2001 | EP1137772A1 Spermatogenesis protein |
| 10/04/2001 | EP1137771A2 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor |
| 10/04/2001 | EP1137769A1 T cells specific for target antigens and methods and vaccines based thereon |
| 10/04/2001 | EP1137768A1 Human hybrid host cell for mammalian gene expression |
| 10/04/2001 | EP1137767A1 Vectors having terminal repeat sequence of epstein-barr virus |
| 10/04/2001 | EP1137764A1 New medical use of gene and vector encoding a multisubstrate deoxyribonucleosidase |
| 10/04/2001 | EP1137763A1 Glucoamylases with n-terminal extensions |
| 10/04/2001 | EP1137762A1 Treatment of pompe's disease |
| 10/04/2001 | EP1137761A1 Cutinase variants |
| 10/04/2001 | EP1137760A1 Bleaching enzymes and detergent compositions comprising them |
| 10/04/2001 | EP1137758A2 Method and composition for preserving viruses |
| 10/04/2001 | EP1137757A1 Dna molecules encoding the melanocortin 5 receptor protein from rhesus monkey |
| 10/04/2001 | EP1137754A2 Method for constructing libraries of phenotypic profiles |
| 10/04/2001 | EP1137665A1 Cark protein and nucleic acid molecules and uses therefor |
| 10/04/2001 | EP1137664A2 Protein transduction system and methods of use thereof |
| 10/04/2001 | EP1137661A1 Procollagen c-proteinase inhibitors |
| 10/04/2001 | EP1137658A1 METHODS OF MODULATING TUMOR NECROSIS FACTOR $g(a)-INDUCED EXPRESSION OF CELL ADHESION MOLECULES |
| 10/04/2001 | EP1137656A1 31 human secreted proteins |
| 10/04/2001 | EP1137434A2 New cancer treatments |
| 10/04/2001 | EP1137423A2 Oral administration of lactobacillus for the treatment and prevention of urogenital infection |
| 10/04/2001 | EP1137418A2 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY |
| 10/04/2001 | EP0973800A4 Novel receptor |
| 10/04/2001 | EP0835309B1 Vaccine for infectious agents, composition for treating and preventing hiv infections |
| 10/04/2001 | EP0835132B1 Recombinant temperature sensitive mutants of influenza virus |
| 10/04/2001 | EP0796343B1 Terminal repeat amplification method |
| 10/04/2001 | EP0784693B1 Viral vectors for gene therapy |
| 10/04/2001 | EP0772632B1 T cell stimulating protein of pestivirus |